Sir William Crookes fue uno de los científicos más destacados del siglo XIX, cuyas contribuciones revolucionarias abarcaron campos tan diversos como la física, la química y la espiritualidad. El Legado de Sir William Crookes en la Ciencia: Nacido el 17 de junio d …
Sir William Crookes: Pionero de la ciencia y explorador de lo desconocido Read More »
Madrigal Pharmaceuticals, Inc. announced the pricing of its underwritten public offering of 750,000 shares of its common stock at a public offering price of $260.0000 per share, and, to certain investors, pre-funded warrants to purchase 1,557,692 shares of common stock at a price of $259.9999 per pre-funded warrant, which represents the per share public offering
Madrigal Pharmaceuticals Announces Pricing of Upsized $600 Million Public Offering Read More »
ObsEva SA announced that, concurrent to the decision to wind-down the company’s operations, Catarina Edfjäll, Ph.D. has decided to step down from the Board effective today.
ObsEva Announces Update on Board of Directors – March 19, 2024 Read More »
AstriVax is pleased to welcome Dr. Gregory Fanning as its Chief Business Officer.
AstriVax Rounds Out Executive Team with Chief Business Officer (CBO) Dr. Gregory Fanning Read More »
Recently, BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement.
Innovent Biologics, Inc. announced that the primary endpoint has been met in the second Phase 2 clinical study of efdamrofusp alfa high-dose, a recombinant human VEGFR-Fc-Human CR1 fusion protein injection, in Chinese subjects with neovascular age-related macular degeneration.
Cognizant is advancing the application of generative AI technology with the NVIDIA BioNeMo platform to solve complex challenges of drug discovery in the life sciences industry, such as improving productivity in the development process and increasing the speed at which new, life-saving treatments can be brought to market.
La luna Titán de Saturno ha fascinado a científicos y entusiastas del espacio durante décadas debido a su atmósfera densa y nebulosa, que es única en nuestro sistema solar. Examinemos el intrigante mundo químico de la atmósfera de Titán, explor …
Asieris Pharmaceuticals announced that the multicenter Phase III global clinical study data of its non-surgical treatment for cervical HSIL product APL-1702 demonstrated significant efficacy and good safety profile, with new advancements in clearance rate of high-risk HPV16 and/or HPV18.
Innate Pharma SA announced that members of its executive team are scheduled to participate in the upcoming investor conference, detailed below.
